FDA Adverse Event Injury Summary report: N

IMPELLA

MDR report key: 24789510 · Received April 6, 2026

Report

Report Number
1220648-2026-06419
Event Type
Injury
Date Received
April 6, 2026
Date of Event
March 27, 2026
Manufacturer
ABIOMED, INC. - 1220648
Product Code
OZD
UDI-DI
00813502012279
PMA / PMN Number
P140003
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IN, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THIS REPORT IS BEING SUBMITTED PURSUANT TO THE PROVISIONS OF 21 CFR, PART 803. THIS REPORT MAY BE BASED ON INFORMATION WHICH HAS NOT BEEN INVESTIGATED OR VERIFIED PRIOR TO THE REQUIRED REPORTING DATE. THIS REPORT DOES NOT REFLECT A CONCLUSION BY ABIOMED INC, OR ITS EMPLOYEES THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE PRODUCT, ABIOMED INC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE POTENTIAL EVENT DESCRIBED IN THIS REPORT. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL REPORT, A FOLLOW-UP REPORT WILL BE FILED AS APPROPRIATE.

Description of Event or Problem · 0

CLINICAL NARRATIVE: AN IMPELLA CP WAS INSERTED VIA THE 14FR INTRODUCER AT THE FEMORAL ARTERY TO SUPPORT THE (B)(6) MALE PATIENT WHO HAD BEEN ADMITTED IN WITH KNOWN CORONARY ARTERY DISEASE AND A PLAN FOR A PROTECTED PERCUTANEOUS CORONARY INTERVENTION (PCI). THE MEDICAL HISTORY WAS NOT SHARED. THE MEDICAL TEAM OBSERVED AN ACCESS SITE HEMATOMA. THE HEMATOMA/BLEEDING WAS REMEDIED QUICKLY AND HEMOSTASIS ACHIEVED WITH THE USE OF 2 PERCLOSE. AT THE CONCLUSION OF THE PCI THE PUMP WAS EXPLANTED. THE PATIENT SURVIVED THE HEMATOMA. ANTICOAGULATION NECESSARY FOR THE PUMP PLACEMENT AND SUPPORT CAN CONTRIBUTE TO ACCESS SITE BLEEDING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
233034 IMPELLA TEMPORARY NON-ROLLER TYPE LEFT HEART SUPPORT BLOOD PUMP OZD ABIOMED, INC. - 1220648 2026792069 00813502012279

Patients

Seq Age Sex Outcome Treatment
1